Direct cleavage of elF4G by poliovirus 2A protease is inefficient in vitro

Virology

Volumn 245, Issue 2, 1998, Pages 241-249

  Bovee, Michael L ^a   Lamphear, Barry J ^b   Rhoads, Robert E ^b   Lloyd, Richard E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E; PROTEINASE; VIRUS ENZYME;

AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVITY; HUMAN; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE ANALYSIS;

COXSACKIEVIRUS; HUMAN RHINOVIRUS SP.; ORYCTOLAGUS CUNICULUS; POLIOVIRUS; RNA VIRUSES;

EID: 0032486249     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9172     Document Type: Article

References (38)

1. Andino R., Rieckhof G. E., Achacoso P. L., Baltimore D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J. 12:1993;3587-3598.
2. Belsham G. J., Sonenberg N. RNA-Protein interactions in regulation of picornavirus RNA translation. Microbiol Rev. 60:1996;499.
3. Benton P. A., Murphy J. W., Lloyd R. E. K562 cell strains differ in their response to poliovirus infection. Virology. 213:1995;7-18.
4. Bernstein H. D., Sonenberg N., Baltimore D. Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol. Cell. Biol. 5:1985;2913-2923.
5. Bonneau A.-M., Sonenberg N. Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection. J. Virol. 61:1987;986-991.
6. Davies M. V., Pelletier J., Meerovitch K., Sonenberg N., Kaufman R. J. The effect of poliovirus proteinase 2Apro expression on cellular metabolism. J. Biol. Chem. 266:1991;14714-14720.
7. Etchison D., Fout S. Human rhinovirus 14 infection of HeLa cells results in the proteolytic cleavage of the p220 cao-binding complex subunit and inactivates globin mRNA translation in vitro. J. Virol. 54:1985;634-638.
8. Etchison D., Hansen J., Ehrenfeld E., Edery I., Sonenberg N., Milburn S., Hershey J. W. B. Demonstration in vitro that eucaryotic initiation factor 3 is active but a cap-binding protein complex is inactive in poliovirus-infected HeLa cells. J. Virol. 51:1984;832-837.
9. Etchison D., Milburn S. C., Edery I., Sonenberg N., Hershey J. W. B. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eukaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257:1982;14806-14810.
10. Etchison D., Smith K. Variations in cap-binding complexes from uninfected and poliovirus-infected HeLa cells. J. Biol. Chem. 265:1990;7492-7500.
11. Grifo J., Tahara S. A., Morgan M. A., Shatkin A. J., Merrick W. C. New initiation factor activity required for globin mRNA translation. J. Biol. Chem. 258:1983;5804-5810.
12. Haghighat A., Svitkin Y., Novoa I., Kuechler E., Skern T., Sonenberg N. The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J. Virol. 70:1996;8444-8450.
13. Haller A. A., Semler B. L. Translation and host cell shutoff. Human Enterovirus Infections. 1995;ASM Press, Washington. p. 113-134.
14. Hellen C. U. T., Lee C.-K., Wimmer E. Determinants of substrate recognition by poliovirus 2A proteinase. J. Virol. 66:1992;3330-3338.
15. Jenkins O., Booth J. D., Minor P. D., Almond J. W. The complete nucleotide sequence of Coxsackievirus B4 and its comparison to other members of the Picornaviridae. J. Gen. Virol. 68:1987;1835-1848.
16. Kirchweger R., Ziegler E., Lamphear B. J., Waters D., Liebig H. D., Sommergruber W., Sobrino F., Hohenadl C., Blaas D., Rhoads R. E., Skern T. Foot-and-mouth disease virus leader proteinase: Purification of the lb form and determination of its cleavage site on eIF-4 gamma. J. Virol. 68:1994;5677-5684.
17. Kräusslich H. G., Nicklin M. J. H., Toyoda H., Etchison D., Wimmer E. Poliovirus proteinase 2A induces cleavage of eukaryotic initiation factor 4F polypeptide p220. J. Virol. 61:1987;2711-2718.
18. Lamphear B. J., Panniers R. Cap binding protein complex that restores protein synthesis in heat-shocked Ehrlich cell lysates contains highly phosphorylated eIF-4E. J. Biol. Chem. 265:1990;5333-5336.
19. Lamphear B. J., Rhoads R. E. A single amino acid change in protein synthesis initiation factor 4G renders cap-dependent translation resistant to picornaviral 2A proteases. Biochemistry. 35:1996;15726-15733.
20. Lamphear B. J., Yan R. Q., Yang F., Waters D., Liebig H. D., Klump H., Kuechler E., Skern T., Rhoads R. E. Mapping the cleavage site in protein synthesis initiation factor-eIF-4γ of the 2A proteases from human coxsackievirus and rhinovirus. J. Biol. Chem. 268:1993;19200-19203.
21. Liebig H. D., Ziegler E., Yan R., Hartmuth K., Klump H., Kowalski H., Blaas D., Sommergruber W., Frasel L., Lamphear B., Rhoads R., Kuechler E., Skern T. Purification of 2 Picornaviral-2A proteinases - Interaction with eIF-4-γ and influence on in vitro translation. Biochemistry. 32:1993;7581-7588.
22. Lloyd R. E., Grubman M. J., Ehrenfeld E. Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequences. J. Virol. 62:1988;4216-4223.
23. Lloyd R. E., Jense H. G., Ehrenfeld E. Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: Relationship to p220 cleavage. J. Virol. 61:1987;2480-2488.
24. Lloyd R. E., Toyoda H., Etchison D., Wimmer E., Ehrenfeld E. Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology. 150:1986;229-303.
25. Morrisey J. H. Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117:1981;307-310.
26. Ohlmann T., Pain V. M., Wood W., Rau M., Morley S. J. The proteolytic cleavage of eukaryotic initiation factor (eIF) 4G is prevented by eIF4E binding protein (PHAS-I, 4E-BP1) in the reticulocyte lysate. EMBO J. 16:1997;844-855.
27. Racaniello V. R., Baltimore D. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. Proc. Natl. Acad. Sci. USA. 78:1981;4887-4891.
28. Roehl H. H., Semler B. L. Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3′ end of viral negative-strand RNA. J. Virol. 69:1995;2954-2961.
29. Skern T., Sommergruber W., Blaas D., Gruendler P., Fraundorfer F., Pieler C., Fogy I., Kuechler E. Human rhinovirus 2: Complete nucleotide sequence and proteolytic processing signals in the capsid region. Nucleic Acids Res. 6:1985;2111-2126.
30. Sommergruber W., Ahorn H., Klump H., Seipelt J., Zoephel A., Fessl F., Krystek E., Blaas D., Kuechler E., Liebig H. D., Skern T. 2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4γ via a common recognition motif. Virology. 198:1994;741-745.
31. Sommergruber W., Ahorn H., Zophel A., Maurerfogy I., Fessl F., Schnorrenberg G., Liebig H. D., Blaas D., Kuechler E., Skern T. Cleavage specificity on synthetic peptide substrates of human rhinovirus-2 Proteinase-2A. J. Biol. Chem. 267:1992;22639-22644.
32. Sommergruber W., Zorn M., Blaas D., Fessl F., Volkmann P., Maurer-Fogy I., Pallai P., Merluzzi V., Matteo M., Skern T., Kuechler E. Polypeptide 2A of human rhinovirus type 2: Identification as a protease and characterization by mutational analysis. Virology. 169:1989;68-77.
33. Sun X.-H., Baltimore D. Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation. Proc. Natl. Acad. Sci. USA. 86:1989;2143-2146.
34. Todd S., Nguyen J. H. C., Semler B. L. RNA-protein interactions directed by the 3′ end of human rhinovirus genomic RNA. J. Virol. 69:1995;3605-3614.
35. Wyckoff E. E., Lloyd R. E., Ehrenfeld E. Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity. J. Virol. 66:1992;2943-2951.
36. Wyckoff E. E., Hershey J. W. B., Ehrenfeld E. Eukaryotic initiation factor-3 is required for poliovirus-2A protease-induced cleavage of the p220 component of eukaryotic initiation factor-4F. Proc. Natl. Acad. Sci. USA. 87:1990;9529-9533.
37. Yalamanchili P., Banerjee R., Dasgupta A. Poliovirus-encoded protease 2Apro cleaves the TATA-binding protein but does not inhibit host cell RNA polymerase II transcription in vitro. J. Virol. 71:1997;6881-6886.
38. Yan R., Rychlik W., Etchison D., Rhoads R. E. Amino acid sequence of the human protein synthesis initiation factor eIF-4γ J. Biol. Chem. 267:1992;23226-23231.